Results 121 to 130 of about 342,150 (384)
Антибиотики и Химиотерапия, 2020 Comparative placebo-controlled study entrolled 647 patients with verified diagnosis of chronic virus hepatitis B (HBeAg+), not previously subjected to antiviral therapy (with nucleotide analogues or interferons).
V. V. Stelmakh +7 more
doaj
HBV-HCV Coinfection: Viral Interactions, Management, and Viral Reactivation
Journal of Clinical and Translational Hepatology, 2018 Hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection is a complex clinical entity that has an estimated worldwide prevalence of 1–15%. Most clinical studies have shown that progression of disease is faster in HBV-HCV coinfected patients ...
Marianna G. Mavilia, George Y Wu
semanticscholar +1 more source
Annals of Gastroenterological Surgery, EarlyView.We retrospectively analyzed clinical data from patients who underwent hepatectomy for hepatocellular carcinoma (HCC) using LCA‐based grading system. These findings provide a new risk stratification framework for the design of precision surgery to treat patients with HCC.
Ling Liu +5 more
wiley +1 more source
Infection and Drug Resistance, 2022 Aiymkul Ashimkhanova,1,* Dmitriy Syssoyev,1,* Arnur Gusmanov,1 Kakharman Yesmembetov,2 Arina Yespotayeva,3 Anara Abbay,1 Aiymzhan Nurpeissova,4 Antonio Sarria-Santamera,1 Abduzhappar Gaipov1 1Department of Medicine, Nazarbayev University School ...
Ashimkhanova A +8 more
doaj
Annals of Gastroenterological Surgery, EarlyView.ABSTRACT Aim Bile acids accumulation in hepatocytes causes liver damage and contributes to the development of hepatocellular carcinoma. However, the association between serum bile acid levels and postoperative intrahepatic recurrence in hepatocellular carcinoma remains unclear.
Tomoaki Bekki +9 more
wiley +1 more source
Hepatic Medicine: Evidence and Research, 2021 Meseret Ayelign,1 Melak Aynalem,2 Nega Berhane3 1Department of Molecular Biology, Specialized Referral Hospital, University of Gondar, Gondar, Ethiopia; 2Department of Hematology and Immunohematology, School of Biomedical and Laboratory Sciences, College
Ayelign M, Aynalem M, Berhane N
doaj
The dynamics of a delay model of hepatitis B virus infection with logistic hepatocyte growth
Mathematical Biosciences and Engineering, 2009 Chronic HBV affects 350 million people and can lead to death through cirrhosis-inducedliver failure or hepatocellular carcinoma. We analyze the dynamics of a model consideringlogistic hepatocyte growth and a standard incidence function governing viral ...
Steffen Eikenberry +3 more
doaj +1 more source
Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations [PDF]
, 1990 The morphologic evolution of hepatitis B virus (HBV) liver disease in 45 hepatic allograft recipients who were HBV surface-antigen positive (HBs-Ag+) at the time of liver replacement and who survived for more than 60 days was studied by routine ...
Demetris, AJ +8 more
core +1 more source
The prevalence of occult hepatitis B virus (hbv) infection in a large multi-ethnic haemodialysis cohort. [PDF]
, 2015 Haemodialysis patients are at increased risk of exposure to blood borne viruses. To reduce transmission in the UK, all haemodialysis patients are regularly screened, and if susceptible to Hepatitis B virus (HBV) infection ...
Cross, J +6 more
core +1 more source
Annals of Gastroenterological Surgery, EarlyView.ABSTRACT The therapeutic landscape of hepatocellular carcinoma (HCC) has been transformed by recent advancements in systemic therapies, particularly with the introduction of immune checkpoint inhibitors, expanding treatment options beyond conventional locoregional approaches.
Keiichi Akahoshi +4 more
wiley +1 more source